A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)

Clinical trial NCT00189813 · COMPLETED

Trial details

NCT number: NCT00189813
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2005-03-01
Primary completion: 2005-12-01
Enrollment: 691

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.